In This Section      

Ebola: Answers to Common Questions

With the heightened media coverage of the Ebola virus disease outbreak, it’s only natural to feel anxious about it. But it’s important to know the facts. 

Information for Our Patients

Has Johns Hopkins Medicine ever dealt with situations like Ebola?

Johns Hopkins Medicine has considerable expertise in and experience with infection control. In our ongoing efforts to protect our patients, health care workers and the general public, we continually scrutinize our infection control practices and train our staff to deal with dangerous situations.

What is Johns Hopkins doing to ensure that patients and visitors are protected?

In our commitment to safety, Johns Hopkins Medicine is following the Centers for Disease Control and Prevention’s guidelines to detect potential cases of Ebola virus disease; protect patients, visitors and staff members; and respond appropriately. Each hospital within our system has identified designated units to care for patients suspected or confirmed to have Ebola. We have reviewed and identified equipment to be used by health care workers and are currently involved in rigorous training for those in teams most likely to care for these patients.

There are no patients with Ebola at The Johns Hopkins Hospital or any other Johns Hopkins Medicine facility.

How do doctors, nurses and other health care workers stay protected and keep from contracting Ebola?

Johns Hopkins Medicine’s health care workers will wear special protective clothing and equipment, and receive extensive, ongoing training to ensure the equipment is used properly and safely. View a brief video about personal protective equipment.

What should I expect when I come to my appointment?

In all care areas where patients are present—inpatient and outpatient settings and emergency departments—we have screenings in place for early identification and isolation of any patient with the relevant travel history and risk factors. Our staff will ask you a series of questions to determine if you are at risk of acquiring Ebola. Based on your responses, the clinical team may perform additional screening.

Learn more by watching Gabor Kelen, M.D., director of the Johns Hopkins Office of Critical Event Preparedness and Response and the Johns Hopkins Department of Emergency Medicine, on Meet the Press.

What does it mean that The Johns Hopkins Hospital is a designated site for potential patients with Ebola?

Being a designated site for patients with Ebola means that the Centers for Disease Control and Prevention recognizes that The Johns Hopkins Hospital has the resources—the facilities, equipment and clinical expertise—to care for a patient confirmed to have Ebola. We are providing extensive training and safety protocols for our clinicians and the best care for our patients. Learn more about The Johns Hopkins Hospital’s role in treating local patients.

Again, there are no patients with Ebola at The Johns Hopkins Hospital or any other Johns Hopkins Medicine facility.

How do I protect myself?

If you travel to affected countries or think you have been exposed to someone suspected or confirmed to have Ebola, follow the Centers for Disease Control and Prevention’s guidance for protecting yourself.


About Johns Hopkins Medicine

What is Johns Hopkins doing to ensure its patients and visitors are protected?

Our staff receives regular training and frequently practices to ensure that our hospitals are prepared for all scenarios. If a patient is suspected to have Ebola virus disease, he or she will be placed in isolation, staff members will take enhanced precautions, and the patient will be evaluated by our specialists in coordination with the Maryland Department of Health and Mental Hygiene.

How do doctors, nurses and other health care workers stay protected and keep from contracting Ebola virus disease?

Johns Hopkins Medicine’s health care workers will wear special protective clothing and equipment, and they are being extensively trained in their proper use. Our infection control teams are training and educating our clinical staff members on proper procedures.


About Ebola

What is Ebola virus disease? What are its symptoms?

Ebola virus is the cause of a viral hemorrhagic fever. Symptoms of Ebola virus disease include fever, severe headache, muscle pain, unexplained bleeding or bruising, vomiting, diarrhea and stomach pain.

How is Ebola virus disease spread?

Ebola virus disease is spread through direct contact with blood or bodily fluids of an infected symptomatic person, or through exposure to objects, such as needles, that have been contaminated with infectious bodily fluids. Standard precautions and safe injection practices are extremely important in preventing the spread of the disease. Ebola virus disease is not believed to be spread through the airborne route, unless the patient is undergoing aerosol-generating procedures—intubation, extubation, bronchoscopy, bilevel positive airway pressure (BiPAP), sputum induction and open suctioning of airways. Individuals who are not symptomatic are not contagious.

How contagious is Ebola virus disease?

We believe that people only become infectious once they start to have symptoms. The risk of becoming infectious in the early course of the disease is generally low. The risk of infection is much higher in the later stages but can be effectively addressed with the proper use of appropriate personal protective equipment.

If I have the virus, how soon will I have symptoms?

Ebola virus disease is a severe acute viral illness that is often characterized by the sudden onset of fever, intense weakness, muscle pain, headache and sore throat. This is followed by vomiting, diarrhea, rash, impaired kidney and liver function, and, in some cases, both internal and external bleeding. Laboratory findings include low white blood cell and platelet counts and elevated liver enzymes. The incubation period, or the time interval from infection to onset of symptoms, is two to 21 days.

Is there a vaccine or treatment for Ebola virus disease?

There is no licensed vaccine for Ebola virus disease, and there are no specific treatments available. Several vaccines are in test phase, and new drug therapies are being evaluated. Severely ill patients require intense supportive care.


About International Travel Recommendations

What are the current recommendations regarding travel to Guinea, Liberia, Mali and Sierra Leone?

The travel guidance above refers to all Johns Hopkins-related travel to Liberia, Guinea, Mali and Sierra Leone. For now, Johns Hopkins-related travel to the rest of West Africa is without restriction, although the guidance will be automatically extended to any country with a CDC Level-3 Travel Advisory for Ebola. CEPAR does not have purview over personal travel decisions. However, we request that employees, students, and volunteers traveling to these countries on personal business unrelated to affiliation with Johns Hopkins register travel plans with the Johns Hopkins International Travel Registry.

How can I stay safe if I travel to these countries?

The best way to stay safe is to avoid travel to these countries and by following the CDC’s advice for avoiding contact with the blood and body fluids of people who are ill with Ebola. For more information, visit Outbreak of Ebola in Guinea, Liberia and Sierra Leone on the CDC Ebola website.

What if I get sick while in these countries?

If you have come into contact with Ebola infected patients and develop symptoms (fever, headache, diarrhea, vomiting, etc.), visit the U.S. Department of State website to find a list of local doctors and hospitals. Many foreign hospitals and clinics are accredited by the Joint Commission International. A list of accredited facilities is available at: Please contact them for assistance. Additionally, delay your travel home until after you have recovered or a qualified medical provider approves return travel.

Is there anything I should do when I return from a country with a Level-3 Travel Advisory?

Should you choose to disregard the Johns Hopkins travel guidance against travel to a country with a Level-3 Travel Advisory, you should keep a symptom/fever journal for 21 days following your trip and immediately inform Occupational Health upon your return.

Has the U.S. Centers for Disease Control issued any health guidance on this issue?

Yes, the CDC is concerned about this public health threat, and has information posted on a special CDC Web page for the general public and health care providers.

Does the CDC have any guidance for travelers to a country with a Level-3 Travel Advisory?

Yes, the CDC says “all non-essential travel to Sierra Leone, Guinea, Mali and Liberia should be avoided.”